MAY-17-13 Please join the Forum in congratulating Nina Mani on an exciting new career move. Nina is leaving the Forum, but she is not going far – starting June 3 she will join the FDA Center for Drug Evaluation Research, Division of Antiviral Products. That we will miss her is the understatement of the century. But the offer to join our colleagues at the FDA as a project manager presented a phenomenal opportunity – an excellent fit for her career path. We congratulate Jeff, Kim, Jules and Patrick on an excellent choice! We imagine that many of you will have the pleasure of interacting with her in her new capacity.
MAY-10-13 We are saddened to report the death of James Goodrich, PhD, MD of ViiV Healthcare, a member of the Forum’s Executive Committee. Jim passed away unexpectedly last weekend and is survived by his wife, Carolyn and two teenage daughters. A memorial service for Jim will be held this summer on a date to be determined.
Jim has been a considered and thoughtful participant on the Executive Committee. His desire to improve care for patients, direct approach and sense of humor will be missed. Please join us in keeping Jim’s family in our thoughts and prayers.
MAY-06-13 Arthur Reingold, MD, professor of epidemiology and associate dean for research at the UC Berkeley School of Public Health, was appointed to the Advisory Committee on Immunization Practices (ACIP) by Secretary Kathleen Sebelius of the Department of Health and Human Services. Learn more>>>
MAY-01-13 On behalf of the HIV/AIDS
community, the Forum for Collaborative HIV Research applauds the U.S. Preventive
Services Task Force for acting to help the estimated 1.2 million Americans now
living with HIV and especially the nearly one in five - an estimated 258,000
people - who don't know they are
infected.
APR-30-13 The USPSTF is calling for HIV screening for all Americans aged 15 to 65, regardless of whether they are considered to be at high risk, a change that may help lift some of the stigma associated with HIV testing. Read more >>
HCV DrAG Meeting #10: Issues in HCV Drug Development
APR-23-13 On April 23rd, the Forum for Collaborative HIV Research convened the 10th HCV Drug Development Advisory Group (DrAG) meeting in Amsterdam, in conjunction with the 48th annual European Association for the Study of the Liver (EASL) conference.
Future of PrEP and Microbicide Research: Trial Design and Regulatory Issues
JAN-07-13With the FDA approval and availability of Truvada for
PrEP, clinical trial design and regulatory issues facing PrEP and microbicide
trials must be considered to facilitate research and development of new
prevention modalities.
DEC-13-12
A scientific roadmap is needed for NGS applications involving viral
species and quasispecies, encompassing technological validation to
clinical utility studies.
Alongside analytical and clinical acceptance criteria, regulatory parameters are needed for: the validation of NGS as a diagnostic assay, NGS-derived data for drug submissions and NGS as a CLIA-governed laboratory-developed test. The Roundtable, a culmination of working group
discussions, aimed to address these issues and outline a framework for
continued dialogue on the aforementioned issues surrounding of NGS.
